Fig 1 - uploaded by Antoine Verger
Content may be subject to copyright.
Typical images of amyloid PET imaging. On the left part, a typical negative amyloid PET with flutemetamol in a 69-year-old man. On the right part, a typical positive amyloid PET with flutemetamol in a 78-year-old man. Images typiques en imagerie TEP amyloïde. À gauche, une TEP amyloïde négative au flutémétamol chez un homme de 69 ans. À droite, une TEP amyloïde positive au flutémétamol chez un homme de 78 ans.

Typical images of amyloid PET imaging. On the left part, a typical negative amyloid PET with flutemetamol in a 69-year-old man. On the right part, a typical positive amyloid PET with flutemetamol in a 78-year-old man. Images typiques en imagerie TEP amyloïde. À gauche, une TEP amyloïde négative au flutémétamol chez un homme de 69 ans. À droite, une TEP amyloïde positive au flutémétamol chez un homme de 78 ans.

Context in source publication

Context 1
... In the report, any areas in which cerebral cortical uptake is more intense than white matter uptake should be noted. The nuclear physician should state clearly whether the scan demonstrates moderate or frequent amyloid deposition in the cerebral cortex (positive result) or not (negative result). Online training programs are currently available. Fig. 1 depicts typical positive and negative amyloid PET scans with flutemetamol. Some tools are currently developed for assisting nuclear medicine physicians in their visual assessment by integrating automatic semi-quantification, quantification possibly detecting earlier pathological deposition [25,26]. In this line, the centiloid scale, ...